Literature DB >> 15950766

Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.

Preeti Parhar1, Rona Ezer, Yongzhao Shao, Jeffrey C Allen, Douglas C Miller, Elizabeth W Newcomb.   

Abstract

Polymorphisms in codon 72 of the p53 tumor suppressor gene have been associated with susceptibility to human cancer. We wished to evaluate whether variant allelic forms of the p53 protein were associated with brain tumors. In this study, we scored 135 brain tumor samples (92 adult and 43 pediatric cases consisting of 64 high-grade astrocytomas and 71 non-astrocytomas) for the P53 Arg72Pro polymorphisms. Our data show that the genotype frequencies of P53 Arg72Pro vary not only between patients with brain tumors and controls, but also between different histological subtypes of brain tumors. Specifically, we found (i) that the genotype distributions of the P53 Arg72Pro between all brain tumors and controls were statistically significant (P < 0.001) as well as their variant allele frequencies between cases and controls (P < 0.001); (ii) that there was a significant increase in the Arg/Pro heterozygous genotype among high-grade astrocytomas compared with non-astrocytomas (P = 0.002); and (iii) that there was a significant increase in the Arg/Pro heterozygous genotype among high-grade astrocytomas containing transdominant as well as recessive p53 mutations compared with controls (P = 0.002). Our results suggest a possible association between P53 Arg72Pro polymorphisms and susceptibility to brain tumors, particularly high-grade astrocytomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950766     DOI: 10.1016/j.molbrainres.2005.02.016

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  14 in total

1.  Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.

Authors:  Feng Zhang; Danni Li; Yanshuang Li; Haixia Li; Jinbo Sun; Xianfeng Li; Xiaohong Li
Journal:  Tumour Biol       Date:  2013-09-18

2.  TP53 codon 72 polymorphism and glioma risk: A meta-analysis.

Authors:  Minghan Shi; Ruishan Huang; Chunying Pei; Xiuzhi Jia; Chuanlu Jiang; Huan Ren
Journal:  Oncol Lett       Date:  2011-12-12       Impact factor: 2.967

Review 3.  Molecular epidemiology of primary brain tumors.

Authors:  Jun Gu; Yanhong Liu; Athanassios P Kyritsis; Melissa L Bondy
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

4.  The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis.

Authors:  Weijie Zhu; Lei Lu; Yi Li; Jie Yao; Bainan Xu
Journal:  Tumour Biol       Date:  2014-02-01

5.  Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.

Authors:  Raimundo M Carvalho; Giovanny R Pinto; France K N Yoshioka; Patrícia D L Lima; Carolina R T Souza; Adriana C Guimarães; Letícia M Lamarão; Juan A Rey; Rommel R Burbano
Journal:  J Neurooncol       Date:  2012-08-11       Impact factor: 4.130

6.  P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.

Authors:  Fang He; Yi Xia; Huafeng Liu; Jin Li; Chao Wang
Journal:  Tumour Biol       Date:  2013-07-17

7.  The potential effect of gender in CYP1A1 and GSTM1 genotype-specific associations with pediatric brain tumor.

Authors:  Lyubov E Salnikova; Olesya B Belopolskaya; Natalya I Zelinskaya; Alexander V Rubanovich
Journal:  Tumour Biol       Date:  2013-05-10

8.  Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.

Authors:  Zhongqiang Lu; Yanyan Cao; Yimin Wang; Qingjun Zhang; Xianghong Zhang; Shuheng Wang; Yuehong Li; Huiling Xie; Baohua Jiao; Jianhui Zhang
Journal:  J Neurooncol       Date:  2007-05-15       Impact factor: 4.130

9.  Association study of xenobiotic detoxication and repair genes with malignant brain tumors in children.

Authors:  L E Salnikova; N I Zelinskaya; O B Belopolskaya; M M Aslanyan; A V Rubanovich
Journal:  Acta Naturae       Date:  2010-10       Impact factor: 1.845

Review 10.  Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.

Authors:  Roman Hrstka; Philip J Coates; Borivoj Vojtesek
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.